|
|
|
|
STRATEGY FOR IMPROVING PRIMARY SEPSIS
OUTCOMES USING LACTATE TESTING
|
|
|
|
|
STRATEGY FOR IMPROVING
PRIMARY SEPSIS OUTCOMES USING LACTATE TESTING
PRESENTERS
Teresa Arrington, MBA, PMP, LSSMBB
System Quality & Patient Safety
Director, Ochsner Health
New Orleans, LA
Lisa Birdsall Fort, MD, MPH
Emergency Medicine
Ochsner Health
New Orleans, LA
SUMMARY
There is a need for expanded POC lactate testing across EDs for
improved sepsis care. Using POCT allows for rapid results from
important labs like lactates, which are a critical part of
clinical decision-making in the context of sepsis.
This webinar covers one hospital system’s journey to incorporate
lactate testing into the standard of care for patients who
present to the ED with symptoms of sepsis, and their successful
‘sepsis drive-team’ structure, with the goal of reducing:
• Delays in patient care
• Testing burden on lab staff
• Morbidity and Mortality |
Learning objectives
- Describe multi-disciplinary, multi-level
structure for sepsis care at a large health system.
- Discuss the high-level process for starting
lactate testing in the ED.
- Analyze POC lactate impact on overall sepsis
outcomes.
- Examine a business case for scaling the
expansion of lactate testing to other areas of the
hospital.
|
Continuing Education:
- One P.A.C.E.®
contact hour will be
provided for this basic level session until June 6, 2024.
Abbott is approved as a provider of continuing
education programs in the clinical laboratory sciences by the
ASCLS P.A.C.E.® Program.
- This session is approved for one
Florida CE credit. Florida Board of Clinical Laboratory
Personnel approved number: 50-12563
Click on 'Recording' to open a recording
request form in your browser. After submitting the form, you
will be redirected automatically to the recording. You
will also be sent an email with the link to the PACE evaluation. A link to your certificate will be emailed
within two weeks of receipt of your completed evaluation.
|
|
|
|
|
EVOLUTION OF SEPSIS GUIDELINES
|
|
|
|
EVOLUTION OF SEPSIS GUIDELINES
PRESENTER
Lori Muhr DNP, MHSM/MHA,
APRN-Rx, ACNS-BC, CCRN, CEN, LSS-BBC
SUMMARY
The Society of Critical Care Medicine
reports that sepsis affects approximately 1.7 million patients
each year, resulting in over 270,000 deaths1. Sepsis
carries a greater mortality than Breast Cancer and AIDS combined2,
costing over $24 billion dollars annually3. Early
identification and treatment has been shown to reduce mortality
by nearly 50% with the completion of the Sepsis Care bundles4.
Over 85% of sepsis patients arrive to the hospital with Sepsis5,
so an evidence-based process for early detection and treatment
is key to reducing complications and mortality.
The Surviving Sepsis Guidelines are a systematic, standardized
evidence-based approach to the early recognition and treatment
of the sepsis patient. Average length of stay (LOS) for the
septic shock patient is 16.5 days with a cost of approximately
$19,000 per case6. Sepsis accounts for 13% of total
U.S. hospital costs7, with early recognition in both
the ED and ICU the average LOS can be reduced8. The
use of the Sepsis Care bundles results in better patient
outcomes, shorter length of stay, and an overall reduction in
sepsis mortality9.
Understanding the evolution of the Sepsis Care bundles and how
each member of the healthcare team can contribute to the
recognition and treatment of sepsis is vital to the patient care
process. A key component of treatment is utilizing the SIRS
(Systemic Inflammatory Response Syndrome) criteria early in the
ED and using the qSOFA (Quick Sequential Organ Failure
Assessment) after admission to help facilitate early sepsis
recognition. |
Learning objectives
- Review the evolution of the Sepsis Care bundles
- Apply the SIRS and qSOFA criteria into practice
- Discuss tools in the risk stratification of
patients diagnosed with sepsis
- Identify the spectrum of organ dysfunction
involved in sepsis
|
Continuing Education:
- One P.A.C.E.®
contact hour will be
provided for this basic level session until March 27, 2023.
Abbott is approved as a provider of continuing
education programs in the clinical laboratory sciences by the
ASCLS P.A.C.E.® Program.
- This session is approved for one
Florida CE credit. Florida Board of Clinical Laboratory
Personnel approved number: 50-12563
- This program has been approved by the American Association of
Critical-Care Nurses (AACN), for 1.00 CERPs, Synergy CERP
Category A, File Number 24306. Approval refers to recognition of
continuing education only and does not imply AACN approval or
endorsement of the content of this educational activity, or the
products mentioned.
After viewing the recording, watch for the evaluation to appear
in your browser. A link to your certificate will be emailed
within two weeks of receipt of your completed evaluation.
|
1Centers
for Disease Control and Prevention. 2021. Sepsis Clinical
Information. [online] Available at: [Accessed 1 June 2021].
2UCLA Health. 2021.
The World Sepsis Day Fact Sheet. [online] Available at:
[Accessed 1 June 2021].
3Paoli, C., 2021.
Epidemiology and Costs of Sepsis in the United States—An
Analysis Based on Timing of Diagnosis and Severity Level.
[online] NCBI. Available at: [Accessed 1 June 2021].
4Vincent, J., 2021.
Reducing mortality in sepsis: new directions. [online] NCBI.
Available at: [Accessed 1 June 2021].
52021. Sepsis Fact
Sheet. [ebook] Available at: [Accessed 1 June 2021].
6Paoli, C., 2021.
Epidemiology and Costs of Sepsis in the United States—An
Analysis Based on Timing of Diagnosis and Severity Level.
[online] NCBI. Available at: [Accessed 1 June 2021].
7Padkin, A., 2021.
Epidemiology of severe sepsis occurring in the first 24 hrs in
intensive care units in England, Wales, and Northern Ireland.
[online] Society of Critical Care Medicine. Available at:
[Accessed 1 June 2021].
8Hackethal, V.,
2018. Fewer Deaths After Sepsis Protocol Mandate. [online]
Medscape. Available at: [Accessed 1 June 2021].
9Hackethal, V.,
2018. Fewer Deaths After Sepsis Protocol Mandate. [online]
Medscape. Available at:
<https://www.medscape.com/viewarticle/901712> [Accessed 1 June
2021]. |
|
|
COVID-19 LESSONS LEARNED SERIES:
RESPIRATORY THERAPY BEST PRACTICES FOR TREATMENT AND PATIENT CARE
STRATEGIES
|
|
|
|
COVID-19
LESSONS LEARNED SERIES:
RESPIRATORY THERAPY BEST PRACTICES FOR TREATMENT AND PATIENT
CARE STRATEGIES
PRESENTER
Vickie Carver-Parker, MBA,
RRT, RPFT
University of Tennessee Medical Center
Knoxville, TN
SUMMARY
As healthcare systems continue
struggle to deal with the impact of the COVID-19 pandemic and
plan for an uncertain future, sweeping changes have occurred
across the healthcare continuum. From ethical staffing
considerations to specific patient care protocols, hospitals
have adjusted multiple processes to deal with the immediate
challenges posed by an influx of patients, while preparing for
the “new normal” that lies ahead.
This webinar will focus on the experiences and lessons learned
from the perspective of an academic medical respiratory therapy
manager. At the conclusion of the presentation, participants
will gain a better understanding of respiratory therapy patient
care strategies, ventilator and treatment protocols, staff and
patient safety recommendations, blood gas testing processes, and
what key steps facilities should take to prepare for a potential
second-wave of increased patient volume as we head into a
respiratory season of unknown severity.
|
Learning objectives
- Identify key recommendations to ensure staff and
patient safety while dealing with a potential
overflow of ICU and ventilator-dependent patients
- Examine key changes to respiratory patient flows
and staffing strategies, as well as ethical
considerations to prepare for additional COVID-19
patient volume
- Discuss respiratory therapy treatment protocols,
vent management and patient care best practices
- Examine resource utilization strategies and best
practices
- Discuss what the “new normal” will look like in
respiratory therapy treatment protocols and ICU
departments
|
Continuing Education:
- One P.A.C.E.®
contact hour will be
provided for this basic level session until April 28, 2021.
Abbott is approved as a provider of continuing
education programs in the clinical laboratory sciences by the
ASCLS P.A.C.E.® Program.
- This session is approved for one
Florida CE credit. Florida Board of Clinical Laboratory
Personnel approved number: 50-12563
- This program has been approved
for 1 CRCE Contact Hour by the American Association for
Respiratory Care (AARC).
- This program has been approved by the American Association of
Critical-Care Nurses (AACN), for 1.00 CERPs, Synergy CERP
Category A, File Number 23275. Approval refers to recognition of
continuing education only and does not imply AACN approval or
endorsement of the content of this educational activity, or the
products mentioned.
After viewing the recording, watch for the evaluation to appear
in your browser. A link to your certificate will be emailed
within two weeks of receipt of your completed evaluation.
|
|
|
LESSONS LEARNED FROM THE EPICENTER
SERIES:
COVID-19 EMERGENCY MEDICINE BEST PRACTICES FROM THE FRONT
LINES OF A HOUSTON, TEXAS MEDICAL CENTER
|
|
|
|
|
LESSONS
LEARNED FROM THE EPICENTER SERIES: COVID-19 EMERGENCY MEDICINE
BEST PRACTICES FROM THE FRONT LINES OF A HOUSTON, TEXAS MEDICAL
CENTER
PRESENTER
W.
Frank Peacock, MD, FACEP, FACC, FESC
Professor, Vice Chair for Research
Henry JN Taub Department of Emergency Medicine
Baylor College of Medicine
Houston, Texas
SUMMARY
As healthcare systems continue to
struggle to deal with the impact of the COVID-19 pandemic and
plan for an uncertain future, sweeping changes have occurred
across the healthcare continuum. From triage strategies to
specific patient care protocols, hospitals have adjusted
multiple processes to deal with the immediate challenges posed
by an influx of patients, while preparing for the “new normal”
that lies ahead.
This second installment of our COVID-19 webinar series will
focus on the experiences and lessons learned from the
perspective of a Houston, Texas emergency department physician.
At the conclusion of the presentation, participants will gain a
better understanding of emergency department triage strategies,
treatment protocols, staff and patient safety recommendations,
lab testing processes, and key steps facilities should take to
prepare for a potential second-wave of increased patient volume
as we head into a flu season of unknown severity.
|
Learning objectives
- Identify key recommendations to ensure staff and
patient safety while dealing with a fragmented
emergency department triage process
- Examine key changes to emergency department
patient flows and co-horting strategies to prepare
for additional COVID-19 patient volume
- Discuss emergency department treatment protocols
and patient care best practices
- Examine resource utilization/PPE strategies and
best practices
- Discuss what the “new normal” will look like in
emergency department operations moving forward
|
Continuing Education:
- One P.A.C.E.®
contact hour will be
provided for this basic level session until March 16, 2021.
Abbott is approved as a provider of continuing
education programs in the clinical laboratory sciences by the
ASCLS P.A.C.E.® Program.
- This session is approved for one
Florida CE credit. Florida Board of Clinical Laboratory
Personnel approved number: 50-12563
- This program has been approved by the American Association of
Critical-Care Nurses (AACN), for 1.00 CERPs, Synergy CERP
Category A, File Number 23275. Approval refers to recognition of
continuing education only and does not imply AACN approval or
endorsement of the content of this educational activity, or the
products mentioned.
After viewing the recording, watch for the evaluation to appear
in your browser. A link to your certificate will be emailed
within two weeks of receipt of your completed evaluation.
|
|
|
LESSONS LEARNED FROM THE EPICENTER
SERIES:
COVID 19 BEST PRACTICES FROM A NEW YORK CITY HOSPITAL
|
|
|
|
|
LESSONS
LEARNED FROM THE EPICENTER: COVID 19 BEST PRACTICES FROM A NEW
YORK CITY HOSPITAL
PRESENTER
Wren Lester, PhD, CPHQ, CPXP, LSSBB
Chief Experience Officer
SUMMARY
As healthcare systems struggle to deal
with the immediate impact of the COVID-19 pandemic and plan for
an uncertain future, sweeping changes have occurred across the
healthcare continuum. Hospitals have adjusted multiple processes
and staffing strategies to deal with the immediate challenges
posed by an influx of patients, while preparing for the “new
normal” that lies ahead.
This webinar will be held in a discussion/interview format and
will focus on the experiences and lessons learned from a
hospital administrator at the center of the initial outbreak in
New York City. At the conclusion of the presentation,
participants will gain a better understanding of work force and
patient safety recommendations, how hospitals must change
patient-care processes, and key steps facilities should take to
prepare for a potential second-wave of increased patient volume.
|
Learning objectives
- Identify strategies to improve the patient and
family experience during COVID-19 isolation
conditions
- Share strategies to maintain employee emotional
well-being under unprecedented working conditions
- Examine key changes in patient workflows to meet
surge demand while maintaining the overall patient
experience
- Discuss procedural changes necessary to ensure
staff and patient safety
- Outline planning strategies to help prepare for
the “new normal”
|
Continuing Education:
- One P.A.C.E.®
contact hour will be
provided for this basic level session until February 11, 2021.
Abbott is approved as a provider of continuing
education programs in the clinical laboratory sciences by the
ASCLS P.A.C.E.® Program.
- This session is approved for one
Florida CE credit. Florida Board of Clinical Laboratory
Personnel approved number: 50-12563
After viewing the recording, watch for the evaluation to appear
in your browser. A link to your certificate will be emailed
within two weeks of receipt of your completed evaluation.
|
|
|
TROPONIN ESSENTIAL GUIDELINES: A
PRACTICAL IMPLEMENTATION GUIDE
|
|
|
|
|
TROPONIN ESSENTIAL
GUIDELINES: A PRACTICAL IMPLEMENTATION GUIDE
PRESENTER
Ruth Cantu, BSN, RN, AACC
Accreditation Product Development
ACC Accreditation Services
SUMMARY
This presentation will address the updates for Myocardial
Infarction Guidelines which are important for clinicians and
laboratorians as they provide valuable information on the new
recommendations for serial Troponins as well as assay
specifications. Information regarding Acute Coronary Syndromes
(ACS) will provide a summary of statistics along with
definitions of indicators under ACS. The methods for treating
Myocardial Infarction (MI), also known as Acute MI or heart
attack, including the acute phase in the ED as well as the
diagnostic expectations for patients in observation status
requiring accelerated serial marker protocols will also be
discussed.
The presentation will include a brief over-view of the
high-sensitive Troponin and discussion on Troponin
Turn-Around-Time (TAT), testing methodologies and a review of
quality practices to optimize patient care. |
Learning objectives
- Review updates to the Myocardial Infarction (MI)
Definition and other relevant guidelines
- Identify guideline-driven best practice
recommendations on the use of biomarkers in the
treatment of Acute Coronary Syndrome (ACS)
- Discuss Troponin turn-around-time (TTAT) and
guideline recommendations for assay use in clinical
practice
- Describe quality practices that optimize the
care and outcomes of ACS patients
|
Continuing Education:
- One P.A.C.E.®
contact hour will be
provided for this basic level session until August 21, 2019.
Abbott is approved as a provider of continuing
education programs in the clinical laboratory sciences by the
ASCLS P.A.C.E.® Program.
- This session is approved for one
Florida CE credit. Florida Board of Clinical Laboratory
Personnel approved number: 50-12563
- This program has been approved by the American
Association of Critical-Care Nurses (AACN) for 1.00 CERPs,
Synergy CERP Category A, File number 22490
After viewing the recording, watch for the evaluation to appear
in your browser. A link to your certificate will be emailed
within two weeks of receipt of your completed evaluation.
|
|
|
PROCESS REDESIGN IN AMBULATORY EMERGENCY
CARE
UTILISING POINT OF CARE TESTING
|
|
|
|
|
PROCESS REDESIGN IN AMBULATORY
EMERGENCY CARE UTILISING
POINT OF CARE TESTING
PRESENTER
Phil Weihser BSc. PGCert. MSc.
James Paget University Hospital NHS Trust, UK
SUMMARY
Emergency departments in many countries are suffering from
overcrowding and increased admission rates. This is due to
numerous factors such as a rise in chronic disease, an ageing
population and access to care.
Many healthcare systems are looking at models of care to help
reduce the burden on acute services by decreasing the length of
stay in hospital, and by reducing the number of unnecessary
admissions.
This webinar highlights how a university hospital in the UK has
tackled the problem, by implementing a 7-day Ambulatory
Emergency Care service (AEC). The speaker will highlight the
clinical, financial and operational benefits achieved through
the novel use of point of care testing, evidence-based service
redesign, condition specific pathways, and access to senior
clinical decision makers. |
Learning objectives
- Discuss how to redesign service in acute and
emergency medicine
- Demonstrate how point-of-care testing pathways
can help drive new models of care
- Examine the potential improvement metrics
including reduction in hospital admissions and
length of stay
|
This event is produced by Whitehat Communications and sponsored
by Abbott Point of Care.
|
|
|
|
|
|
|
ACT TESTING
|
|
|
|
|
|
ACT
TESTING:
WHEN THERE'S NO ROOM FOR DOUBT
PRESENTER
Dr. Florian Falter, MD
Royal Papworth Hospital, UK
SUMMARY
ACT tests with some traditional
analysers can lead to highly variable results, raising doubt
about the accuracy of critical results1. Additionally, some
second generation systems have diverged from using the
traditional standard Celite and Kaolin activator biochemistry.
In this educational webinar, Dr.Falter
will introduce different ACT technologies and discuss best use
of modern ACT testing technology. He will also discuss the
clinical impact that different ACT analysis methods can have,
along with key laboratory aspects of coagulation testing during
cardiac surgery.
1 Reference: Ojito JW et al. J Extra
Corpor Technol 2012;44:15-20 |
Learning objectives
- Examine laboratory requirements of test accuracy
and reliability
- Differentiate between laboratory and point of
care approach to intra-operative coagulation testing
during cardiac surgery
- Identify the various methods of assessing
heparin activity
- Assess the technological differences between
different methods of measuring the Activated
Clotting Time (ACT)
- Evaluate the clinical impact of the different
ACT technologies
|
Continuing Education:
One P.A.C.E.® contact hour will be
provided for this basic level session until December 4, 2018.
Whitehat Communications is approved as a provider of continuing
education programs in the clinical laboratory sciences by the
ASCLS P.A.C.E.® Program.
This session is approved for one
Florida CE credit. Florida Board of Clinical Laboratory
Personnel approved number: 50-12563
This event is produced by Whitehat Communications and sponsored
by Abbott Point of Care.
|
|
|
|
|
|
|
|
|
TROPONIN ESSENTIALS
|
|
|
|
|
|
TROPONIN ESSENTIALS:
IMPLEMENTING THE GUIDELINES
PRESENTER
Ruth Cantu,
BSN, RN, AACC
Program Manager, ACC Accreditation Services
Summary
The detection of a rise and/or
fall of cardiac troponin plays a key role in identification of
patients suspected of having an Acute Coronary Syndrome (ACS)
and earlier diagnosis of myocardial infarction. However,
individuals with non-ACS conditions can also have elevated
cardiac troponin and many symptoms associated with non-ACS
conditions may overlap with symptoms of ACS1. This presents a
diagnostic challenge to the clinician and often requires an
extended evaluation before the clinician can make an accurate
diagnosis, which can impact efficiency and quality of care. This
webinar will share an evidence-based approach to diagnosis and
treatment of the ACS patient, with a focus on the current
guidelines for troponin testing. |
Learning objectives
- Identify guideline-driven best practice
recommendations on the use of biomarkers in the
treatment of Acute Coronary Syndrome (ACS)
- Review updates to the Myocardial Infarction (MI)
Definition and Non-ST elevation Acute Coronary
Syndromes (NSTE-ACS) guidelines
- Discuss troponin turn-around-time
recommendations and documentation requirements
- Share quality practices that optimize the care
and outcomes of ACS patients
|
|
Reference: 1. Third
Universal Definition of Myocardial Infarction (MI), Kristian
Thygesen, Joseph S. Alpert, Allan S. Jaffe, Maarten L. Simoons,
Bernard R. Chaitman and Harvey D. White, Circulation
2012;126:2020-2035
www.scpc.org/resources/PDFs/ThirdUniversalDefinitionofMyocardialInfarction_CIRC2012.pdf |
|
|
|
|